Skip to main content
    S

    Solesence, Inc. Common Stock (SLSN)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $1.60
    +0.08 (+5.26%)

    Market Cap: $107.38M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Solesence, Inc. Common Stock (SLSN) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Solesence, Inc. Common Stock (SLSN) trades at 19.7x trailing earnings and 1.9x sales. Its P/B of 6.7x is below its 5-year median of 12.5x. Its forward P/E is 11.4x. The median P/E across 5 similar companies is 11.1x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 72.8% higher over the next year. Its free cash flow yield is 7.3%.

    MultipleValue
    P/E (trailing)19.7x
    Forward P/E11.4x
    Price to sales1.9x
    Price to book6.7x
    EV/EBITDA23.2x
    Price to FCF13.7x
    EV/FCF14.6x
    PEGN/A
    FCF yield7.3%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 38.5% below 10.9x.

    MultipleCurrent5-year median10-year median
    P/B6.7x12.5x10.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 32.9x in 2020 to 66.9x in 2021.

    Year endPriceP/EP/SP/B
    2025$1.6058.2x1.8x6.6x
    2024$2.4439.2x2.9x11.4x
    2023$0.60N/A0.8x15.7x
    2022$1.13N/AN/A7.5x
    2021$4.4066.9xN/A27.6x
    2020$0.8532.9xN/A13.1x
    2019$0.28N/AN/A8.7x
    2018$0.73N/AN/A10.2x
    2017$0.52N/AN/A6.9x
    2016$0.72N/AN/A6.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SLSN

    What is SLSN's forward P/E ratio?

    Solesence, Inc. Common Stock has a forward P/E ratio of 11.4x.

    Is SLSN stock overvalued?

    GNG's valuation label for SLSN is Undervalued. Its P/E of 19.7x compares with a median of 11.1x across 5 similar companies.

    What is SLSN's price to sales ratio?

    Solesence, Inc. Common Stock has a price to sales ratio of 1.9x.